Skip to content

Blue-Blocking IOLs in Combined Surgery

Blue Light-Filter IOLs in Vitrectomy Combined With Cataract Surgery: Results of a Randomized Controlled Clinical Trial.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00537992
Enrollment
60
Registered
2007-10-02
Start date
2004-10-31
Completion date
2006-03-31
Last updated
2007-10-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cataract, Epiretinal Membranes, Macular Holes

Keywords

combined surgery,, cataract surgery,, vitrectomy,, blue light-filter iols

Brief summary

Although commonly used in cataract surgery, the use of the blue light-filter IOLs in vitrectomy combined with cataract surgery has not been reported yet. A prospective controlled clinical trial was designed to evaluate the effect of the blue light-filter IOL on the surgeon's ability to perform specific vitreoretinal procedures and on the patients' outcome.

Detailed description

Sixty patients were randomly assigned to receive a UV-filter IOL (transparent IOL group) or a blue light-filter IOL (yellow IOL group) combined with a vitreoretinal procedure. Outcome measures were intraoperative conditions for the surgeon, complication rates, the functional outcome and vitreoretinal diagnoses.

Interventions

UV-filter IOL (transparent IOL group) or a blue light-filter IOL (yellow IOL group) combined with a vitreoretinal procedure

Sponsors

The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
50 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Diagnosis vitreoretinal pathology (diabetic vitreous hemorrhage, macular hole, epiretinal membrane or persisting macula edema) * Coexisting significant cataract * The need for combined surgery ( pars plana vitrectomy, phacoemulsification and IOL implantation) * Age over 50 years.

Exclusion criteria

* Pseudophakia on the non-study eye * The need for silicone oil tamponade * Optic atrophy.

Design outcomes

Primary

MeasureTime frame
intraoperative conditions for the surgeon (scaled questionnaire) and patients´ outcome

Secondary

MeasureTime frame
complication rates and vitreoretinal diagnoses

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026